A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment
In 2023, researchers at Baylor College of Medicine led by the late Dr. Bert O'Malley discovered that the steroid receptor coactivator 3 (SRC-3) in immune cells called regulatory T cells (Tregs) plays a decisive role in shaping ...
Mar 26, 2026
0
6









